Novabay Pharmaceuticals Inc (NBY) Live Share Price, Invest From India

Novabay Pharmaceuticals Inc Stock Performance

as on April 3, 2026 at 6:59 am IST

Day's Low
Day's High
$1.57
Day's Price Range
$1.98
$1.97
20.30%
Downside
0.51%
Upside
52 Week's Low
52 Week's High
$1.11
52-Week Price Range
$99.75
$1.97
43.65%
Downside
4963.45%
Upside

Novabay Pharmaceuticals Inc share price movements today

Previous Close: $1.59
Open: $1.58
Volume: 887.7K
Day's Low - High: $1.57 - $1.98
52 Week Low - High: $1.11 - $99.75

Novabay Pharmaceuticals Inc Historical Returns

1 Month Return: 0 %
3 Month Return: 0 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Novabay Pharmaceuticals Inc Stock Fundamentals & Key Indicators

Check Novabay Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

EPS (TTM)

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

0.00%

Novabay Pharmaceuticals Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Novabay Pharmaceuticals Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Novabay Pharmaceuticals Inc	BUY	$-	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$42.3B	124.53%	136.85	8.45%
Beone Medicines Ltd	NA	$35.7B	NA	126.85	5.37%
Vertex Pharmaceuticals Incorporated	BUY	$111.4B	103.77%	28.66	32.94%
Regeneron Pharmaceuticals, Inc.	BUY	$80.5B	59.16%	18.38	31.41%

Analyst Recommendation on Novabay Pharmaceuticals Inc Stock

Based on 6 analysts

BUY

83.33%

Buy

16.67%

Hold

0.00%

Sell

Based on 6 analysts, 83.33% of analysts recommend a 'BUY' rating for Novabay Pharmaceuticals Inc. Average target price of $0.85

Novabay Pharmaceuticals Inc Share Price Target

Get share price movements and forecasts by analysts on Novabay Pharmaceuticals Inc.

What analysts predicted

-131.76%DOWNSIDE

Target Price

$0.85

Current Price

$1.97

Analyzed by

6 Analysts

Target

$0.85

Novabay Pharmaceuticals Inc target price $0.85, a slight downside of -131.76% compared to current price of $1.97. According to 6 analysts rating.

Novabay Pharmaceuticals Inc Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	3	3	2	2	2	2	2	-	0	0
Gross Profit	1	1	1	1	1	1	1	0	0	0
Operating Income	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-1	-4	-3	-1	-1	-1	7	-1	-1	-26
Net Profit Margin	-53.98%	-110.22%	-122.16%	-66.04%	-49.65%	-52.49%	332.18%	0.00%	-248.18%	5104.80%

Novabay Pharmaceuticals Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	11	18	12	6	9	10	14	10	9	-
Gross Profit	9	15	11	4	5	6	7	6	6	0
Operating Income	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-13	-7	-6	-9	-11	-5	-10	-9	-7	-22
Net Profit Margin	-110.54%	-40.61%	-52.33%	-146.36%	-111.12%	-57.08%	-73.65%	-92.20%	-73.85%	0.00%

Insights on Novabay Pharmaceuticals Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 7 days, NBY stock has moved up by 30.0%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 57.3% return, outperforming this stock by 156.6%
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 35.3% return, outperforming this stock by 59.8%
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, -1.29M → -26.59M (in $), with an average decrease of 1956.9% per quarter
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 5 quarters, 2.44M → -521.0K (in $), with an average decrease of 70.7% per quarter

About Novabay Pharmaceuticals Inc

NovaBay Pharmaceuticals, Inc. is engaged in wound care products. The Company manufactures and sells its proprietary form of hypochlorous acid for the wound care market through its NeutroPhase and PhaseOne branded products. NeutroPhase and PhaseOne are used for cleansing and irrigation as part of surgical procedures, as well as treating wounds, burns, ulcers and other injuries.

Organisation	Novabay Pharmaceuticals Inc
E-voting on shares	Click here to vote

FAQs

What is Novabay Pharmaceuticals Inc share price today?

Novabay Pharmaceuticals Inc share price today is $1.97 as on April 3, 2026 at 1:29 am IST at the close of the market. Novabay Pharmaceuticals Inc share today touched a day high of $1.98 and a low of $1.57.

What is the 52 week high and 52 week low for Novabay Pharmaceuticals Inc share?

Novabay Pharmaceuticals Inc share touched a 52 week high of $99.75 on January 9, 2026 and a 52 week low of $1.11 on March 9, 2026. Novabay Pharmaceuticals Inc stock price today i.e. April 3, 2026 at 1:29 am IST is closed at $1.97,which is 98.03% down from its 52 week high and 77.48% up from its 52 week low.

How to invest in Novabay Pharmaceuticals Inc Stock (NBY) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Novabay Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Novabay Pharmaceuticals Inc Shares that will get you 0.7614 shares as per Novabay Pharmaceuticals Inc share price of $1.97 per share as on April 3, 2026 at 1:29 am IST.

What is the minimum amount required to buy Novabay Pharmaceuticals Inc Stock (NBY) from India?

Indian investors can start investing in Novabay Pharmaceuticals Inc (NBY) shares with as little as ₹92.67 or $1 (as of April 6, 2026 at 3:01 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹926.70 in Novabay Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on April 6, 2026 at 3:01 pm IST). Based on Novabay Pharmaceuticals Inc share’s latest price of $1.97 as on April 3, 2026 at 1:29 am IST, you will get 5.0761 shares of Novabay Pharmaceuticals Inc. Learn more about fractional shares .